Determining the molecular mechanisms by which p53 controls Oma1-mediated L-Opa1 processing may advance the current understanding of mitochondrial dynamics and apoptosis, and ultimately of the mechanisms of chemoresistance in human gynecologic cancer. This evidence concerns the gene OMA1 and female reproductive organ cancer.